Kathryn E. Ware

2.0k citations

27 papers · 1.5k indexed · h-index 16

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Oncology top 5%
- Cancer Cells and Metastasis

Papers in ⓘ

Pulmonary and Respiratory Medicine 18
- Prostate Cancer Treatment and Research 7
- Sarcoma Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 4
Molecular Biology 13
- Fibroblast Growth Factor Research 5

Co-authors: Jason A. Somarelli (18 shared papers)Mohit Kumar Jolly (7 shared papers)Herbert Levine (4 shared papers)Shivee Gilja (4 shared papers)Lynn E. Heasley (6 shared papers)Andrew J. Armstrong (11 shared papers)Lindsay A. Marek (5 shared papers)Mariano A. García-Blanco (4 shared papers)
Journals: Clinical Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of Visualized Experiments (2 papers)Evolution Medicine and Public Health (2 papers)Cancer Research (2 papers)
Partner nations: United States India United Kingdom

In The Last Decade

Kathryn E. Ware

26 papers receiving 1.4k citations

Peers

Countries citing papers authored by Kathryn E. Ware

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Ware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Ware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Ware more than expected).

Fields of papers citing papers by Kathryn E. Ware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Ware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Ware. The network helps show where Kathryn E. Ware may publish in the future.

Co-authors

The 25 scholars most cited alongside Kathryn E. Ware, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathryn E. Ware Line = papers co-authored together Kathryn E. Ware links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	EMT and MET : necessary or permissive for metastasis? Molecular Oncology ·Mohit Kumar Jolly, Kathryn E. Ware, Shivee Gilja, Jason A. Somarelli, Herbert Levine	2017	282
2	Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells Molecular Pharmacology ·Lindsay A. Marek, Kathryn E. Ware, Alexa Fritzsche, Paula Hercule, Wallace R. Helton, Jennifer E. Smith, Lee McDermott, Christopher D. Coldren, Raphael A. Nemenoff, Daniel T. Merrick, Barbara A. Helfrich, Paul A. Bunn, Lynn E. Heasley	2008	180
3	FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies Clinical Cancer Research ·Murry W. Wynes, Trista K. Hinz, Dexiang Gao, Michael L. Martini, Lindsay A. Marek, Kathryn E. Ware, Michael G. Edwards, Diana Böhm, Sven Perner, Barbara A. Helfrich, Rafał Dziadziuszko, Jacek Jassem, Szymon Wojtylak, Aleksandra Sejda, Joseph M. Gozgit, Paul A. Bunn, D. Ross Camidge, Aik Choon Tan, Fred R. Hirsch, Lynn E. Heasley	2014	125
4	Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression PLoS ONE ·Kathryn E. Ware, Marianne E. Marshall, Lydia R. Heasley, Lindsay A. Marek, Trista K. Hinz, Paula Hercule, Barbara A. Helfrich, Robert C. Doebele, Lynn E. Heasley	2010	123
5	Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity Molecular Cancer Therapeutics ·Amy K. Keating, Grace K. Kim, Ashley E. Jones, Andrew M. Donson, Kathryn E. Ware, Jean M. Mulcahy, Dana Salzberg, Nicholas K. Foreman, Xiayuan Liang, Andrew Thorburn, Douglas K. Graham	2010	120
6	Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer Endocrine Related Cancer ·Kathryn E. Ware, Mariano A. García-Blanco, Andrew J. Armstrong, Scott M. Dehm	2014	105
7	Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells Clinical Cancer Research ·Marianne E. Marshall, Trista K. Hinz, Scott A. Kono, Katherine R. Singleton, Brady Bichon, Kathryn E. Ware, Lindsay A. Marek, Barbara Frederick, David Raben, Lynn E. Heasley	2011	84
8	Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2 Molecular and Cellular Biology ·Jason A. Somarelli, Samantha Shetler, Mohit Kumar Jolly, Xueyang Wang, Suzanne Bartholf DeWitt, Alexander J. Hish, Shivee Gilja, William C. Eward, Kathryn E. Ware, Herbert Levine, Andrew J. Armstrong, Mariano A. García-Blanco	2016	68
9	EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases Cancer Research ·Aria Vaishnavi, Laura Schubert, Uwe Rix, Lindsay A. Marek, Anh T. Le, Stephen B. Keysar, Magdalena J. Glogowska, Matthew A. Smith, Severine Kako, Natália J. Sumi, Kurtis D. Davies, Kathryn E. Ware, Marileila Varella‐Garcia, Eric B. Haura, Antonio Jimeno, Lynn E. Heasley, Dara L. Aisner, Robert C. Doebele	2017	61
10	The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer Drug Resistance Updates ·Scott A. Kono, Marianne E. Marshall, Kathryn E. Ware, Lynn E. Heasley	2009	57
11	Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Santosh Gupta, Jing Li, Gabor Kemeny, Rhonda L. Bitting, Joshua Beaver, Jason A. Somarelli, Kathryn E. Ware, Simon G. Gregory, Andrew J. Armstrong	2016	52
12	Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer Oncotarget ·Kathryn E. Ware, Jason A. Somarelli, Daneen Schaeffer, Jing Li, Tian Zhang, Sally Park, Steven R. Patierno, Jennifer A. Freedman, Wen-Chi Foo, Mariano A. García-Blanco, Andrew J. Armstrong	2016	40
13	Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer Biomarker Research ·Tian Zhang, Anika Agarwal, R. Garland Almquist, Daniella Runyambo, Sally Park, Elizabeth Bronson, Rengasamy Boominathan, Chandra Rao, Monika Anand, Taofik Oyekunle, Patrick Healy, Megan McNamara, Kathryn E. Ware, Jason A. Somarelli, Daniel J. George, Andrew J. Armstrong	2021	31
14	A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer Molecular Cancer Therapeutics ·Jason A. Somarelli, Roham Salman Roghani, Ali Sanjari Moghaddam, Beatrice C. Thomas, Gabrielle Rupprecht, Kathryn E. Ware, Erdem Altunel, John B. Mantyh, So Young Kim, Shannon J. McCall, Xiling Shen, Christopher R. Mantyh, David S. Hsu	2020	25
15	PhyloOncology: Understanding cancer through phylogenetic analysis Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Jason A. Somarelli, Kathryn E. Ware, Rumen Kostadinov, Jeffrey Robinson, Hakima Amri, Mones Abu‐Asab, Nicolaas H. Fourie, Rui Diogo, David L. Swofford, Jeffrey P. Townsend	2016	24
16	From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine Frontiers in Oncology ·Sneha Rao, Jason A. Somarelli, Erdem Altunel, Laura E. Selmic, Mark Byrum, Maya U. Sheth, Serene Cheng, Kathryn E. Ware, So Young Kim, Joseph A. Prinz, Nicolas Devos, David L. Corcoran, Arthur Moseley, Erik J. Soderblom, Shiaowen David Hsu, William C. Eward	2020	16
17	Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer BMC Cancer ·Erdem Altunel, Roham Salman Roghani, Kai‐Yuan Chen, So Young Kim, Shannon J. McCall, Kathryn E. Ware, Xiling Shen, Jason A. Somarelli, David S. Hsu	2020	14
18	A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma Cancers ·Jason A. Somarelli, Gabrielle Rupprecht, Erdem Altunel, Etienne M. Flamant, Sneha Rao, Dharshan Sivaraj, Alexander L. Lazarides, Sarah M. Hoskinson, Maya U. Sheth, Serene Cheng, So Young Kim, Kathryn E. Ware, Anika Agarwal, Mark M. Cullen, Laura E. Selmic, Jeffrey I. Everitt, Shannon J. McCall, Cindy Eward, William C. Eward, David S. Hsu	2020	13
19	An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance Journal of Clinical Medicine ·Shengnan Xu, Kathryn E. Ware, Yuantong Ding, So Young Kim, Maya U. Sheth, Sneha Rao, Wesley Chan, Andrew J. Armstrong, William C. Eward, Mohit Kumar Jolly, Jason A. Somarelli	2019	13
20	Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells Journal of Visualized Experiments ·Kathryn E. Ware, Shivee Gilja, Shenghan Xu, Samantha Shetler, Mohit Kumar Jolly, Xueyang Wang, Suzanne Bartholf DeWitt, Alexander J. Hish, Sarah Jordan, William C. Eward, Herbert Levine, Andrew J. Armstrong, Jason A. Somarelli	2017	7

About Kathryn E. Ware

Kathryn E. Ware is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Genetics, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Prostate Cancer Treatment and Research (7 papers), Cancer Cells and Metastasis (5 papers), Fibroblast Growth Factor Research (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), MicroRNA in disease regulation (2 papers) and Hormonal and reproductive studies (2 papers). The work is most often cited by research in Cancer Research (399 citations), Oncology (548 citations), Pulmonary and Respiratory Medicine (513 citations), Molecular Biology (870 citations) and Cell Biology (149 citations). Kathryn E. Ware has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Jason A. Somarelli, Mohit Kumar Jolly, Herbert Levine, Shivee Gilja, Lynn E. Heasley, Andrew J. Armstrong, Lindsay A. Marek, Mariano A. García-Blanco, Barbara A. Helfrich and Trista K. Hinz. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer Therapeutics, Journal of Visualized Experiments, Evolution Medicine and Public Health and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact